Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05056753 · ClinicalTrials.gov registry record · NA
Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety
A NA study, sponsored by PhotoPharmics.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05056753 is a NA study that has completed, run by PhotoPharmics. The registered enrollment target is 80 participants.
The verdict
NCT05056753, a NA study, has completed, sponsored by PhotoPharmics.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
In this randomized, double-blind, controlled, parallel group study (conducted over 12-months), enrollment is expected of up to 60 subjects (30 men and 30 women) ages 18+ who are currently going through withdrawal of OUD and being treated at local substance abuse clinics. The study visits will include screening, baseline, Weeks 1, 2, 3, and 4, with both safety and efficacy assessments.
Interventions
- DEVICE HWBV chair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-01-20 |
| Est. Completion | 2023-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05056753
The ClinicalTrials.gov registry entry for NCT05056753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PhotoPharmics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HWBV chair is the first listed.
NCT05056753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05056753 about?
NCT05056753 is a clinical study titled "Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety". In this randomized, double-blind, controlled, parallel group study (conducted over 12-months), enrollment is expected of up to 60 subjects (30 men and 30 women) ages 18+ who are currently going through withdrawal of OUD and being treated at local substance abuse clinics. The study visits will includ...
What is the current status of trial NCT05056753?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2022-01-20. Estimated completion is 2023-07-30.
What interventions are being tested in trial NCT05056753?
The interventions under investigation include: HWBV chair (DEVICE).
Who is sponsoring clinical trial NCT05056753?
This trial is sponsored by PhotoPharmics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.